We are live on !
Find out more
EMB
Elefante Mark B Portfolio holdings
AUM
$232M
Turnover
9.68%
1-Year Est. Return
39.33%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+39.33%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.64M
AUM Growth
+$379K
(+6.1%)
Cap. Flow
+$270K
Cap. Flow % of AUM
Cap. Flow %
4.07%
Top 10 Holdings %
Top 10 Hldgs %
58.69%
Holding
21
New
1
Increased
9
Reduced
1
Closed
–
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$204K |
| 2 |
Chubb
CB
|
+$22.2K |
| 3 |
Novartis
NVS
|
+$17K |
| 4 |
Abbott
ABT
|
+$12.7K |
| 5 |
RTX Corp
RTX
|
+$9.15K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fiserv Inc
FISV
|
+$15.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.23% |
| 2 | Technology | 21.45% |
| 3 | Industrials | 13.34% |
| 4 | Consumer Staples | 12.27% |
| 5 | Financials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Fiserv Inc
FISV
$33.8B
| $544K | 8.19% |
10,020
-300
| -3% | -$15.4K |
2015 Q4
2 quarters
|
|
2
CVS Health
CVS
$109B
| $527K | 7.93% |
5,510
| – | – |
2015 Q4
2 quarters
|
|
3
Johnson & Johnson
JNJ
$679B
| $434K | 6.53% |
3,585
+50
| +1% | +$5.68K |
2015 Q4
2 quarters
|
|
4
Procter & Gamble
PG
$390B
| $364K | 5.48% |
4,295
| – | – |
2015 Q4
2 quarters
|
|
5
Mastercard
MA
$571B
| $349K | 5.25% |
3,970
| – | – |
2015 Q4
2 quarters
|
|
6
3M
MMM
$97.3B
| $348K | 5.24% |
2,374
+12
| +0.5% | +$1.69K |
2016 Q1
1 quarter
|
|
7
Automatic Data Processing
ADP
$119B
| $347K | 5.22% |
3,780
| – | – |
2015 Q4
2 quarters
|
|
8
Apple
AAPL
$5.1T
| $331K | 4.98% |
13,888
+200
| +1% | +$4.97K |
2015 Q4
2 quarters
|
|
9
AptarGroup
ATR
$9.14B
| $327K | 4.92% |
4,135
| – | – |
2015 Q4
2 quarters
|
|
|
10
Novartis
NVS
$309B
| $314K | 4.73% |
4,252
+246
| +6% | +$17K |
2015 Q4
2 quarters
|
|
|
11
RTX Corp
RTX
$265B
| $301K | 4.53% |
4,672
+143
| +3% | +$9.15K |
2015 Q4
2 quarters
|
|
|
12
Chubb
CB
$139B
| $274K | 4.12% |
2,103
+180
| +9% | +$22.2K |
2016 Q1
1 quarter
|
|
13
Alphabet (Google) Class A
GOOGL
$3.54T
| $257K | 3.87% |
7,300
+200
| +3% | +$7.34K |
2015 Q4
2 quarters
|
|
14
ExxonMobil
XOM
$672B
| $257K | 3.87% |
2,727
+15
| +0.6% | +$1.33K |
2016 Q1
1 quarter
|
|
15
SLB Ltd
SLB
$74.4B
| $243K | 3.66% |
3,070
| – | – |
2016 Q1
1 quarter
|
|
16
Rockwell Automation
ROK
$43.2B
| $237K | 3.57% |
2,065
| – | – |
2015 Q4
2 quarters
|
|
17
PepsiCo
PEP
$193B
| $236K | 3.55% |
2,232
| – | – |
2016 Q1
1 quarter
|
|
|
18
Unilever
UL
$143B
| $215K | 3.24% |
+3,969
| New | +$204K |
2016 Q2
0 quarters
|
|
|
19
Abbott
ABT
$191B
| $207K | 3.12% |
5,285
+320
| +6% | +$12.7K |
2015 Q4
2 quarters
|
|
20
Oracle
ORCL
$373B
| $203K | 3.06% |
4,955
| – | – |
2016 Q1
1 quarter
|
|
Similar funds
PC
WM
Elefante Mark B's Q2 2016 Portfolio in Review
As of Q2 2016, Elefante Mark B held 21 positions worth $6.64M, up 6.1% from $6.26M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Elefante Mark B deployed $270K of net new capital in Q2 2016, opening 1 new position and adding to 9 existing holdings. Its largest new stake was Unilever: 3,969 shares worth $215K.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Fiserv Inc, an estimated $15.4K trimmed.
- Elefante Mark B's largest Q2 2016 buy was Unilever: 3,969 shares worth $215K.
- Elefante Mark B added most to Chubb in Q2 2016, an estimated $22.2K increase.
- Elefante Mark B's biggest Q2 2016 reduction was Fiserv Inc, cutting an estimated $15.4K.
- Elefante Mark B's ten largest holdings make up 59% of its $6.64M portfolio in Q2 2016.
- Elefante Mark B opened 1 new position and closed 0 in Q2 2016.
- Elefante Mark B's portfolio value rose 6.1% quarter-over-quarter to $6.64M.
Based on Elefante Mark B's 13F filing for Q2 2016, filed 8 Aug 2016.